Alpha 1-Antitrypsin Deficiency - 72 Studies Found
Recruiting |
: Ph 3/4 GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study : Alpha1-antitrypsin Deficiency : 2015-08-14 : Biological: GLASSIA 60 mg/kg BW administered at a rate of 0.2 mL/kg/min |
Completed |
: Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor) : Alpha 1-Antitrypsin Deficiency : 2006-11-03 : Biological: Alpha1-Proteinase Inhibitor 60 mg/kg, weekly, intravenous infusion |
Recruiting |
: Alpha-1 Foundation Research Registry : Alpha 1-Antitrypsin Deficiency : 2007-07-11 |
Completed |
: Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation. : Alpha 1 Antitrypsin Deficiency : 2012-08-14 : Drug: Alpha-1 Antitrypsin (human) Comparison of Zemaira (Alpha 1 Antitrypsin Human) 120 mg/kg/weekly for |
Active, not recruiting |
: Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (AATD) :
|
Completed |
: The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency : Alpha 1-Antitrypsin Deficiency : 2006-03-08 : Drug: alpha-1 proteinase inhibitor (human) 60 mg/kg weekly for 20 weeks |
Recruiting |
: Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency :
|
Recruiting |
: Alpha-1 Coded Testing(ACT) Study : Alpha-1 Antitrypsin Deficiency : 2007-07-11 : Procedure: Alpha-1 Antitrypsin Genotype Home fingerstick testing for alpha-1 antitrypsin genotype |
Not yet recruiting |
: Safety Study of Gene Transfer Vector to Treat Alpha1-antitrypsin (A1AT) Deficiency : Alpha 1-Antitrypsin Deficiency : 2014-06-10 : Genetic: ADVM-043 gene transfer vector administration |
Completed |
: Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home : Alpha 1-Antitrypsin Deficiency : 2012-08-29 |